Sarcoma

Top Story

FDA approves Tazverik for advanced epithelioid sarcoma

FDA approves Tazverik for advanced epithelioid sarcoma
January 24, 2020
In the Journals

Talimogene laherparepvec-pembrolizumab combination appears safe, effective in advanced sarcoma

January 23, 2020
Talimogene laherparepvec in combination with pembrolizumab demonstrated antitumor activity among patients with advanced sarcoma across a range of histologic subtypes…
FDA News

FDA approves Ayvakit for unresectable, metastatic gastrointestinal stromal tumors harboring rare mutation

January 9, 2020
The FDA today approved avapritinib for the treatment of adults with unresectable or metastatic gastrointestinal stromal tumors that harbor a platelet-derived growth…
FDA News

FDA advisory committee unanimously supports approval of tazemetostat for epithelioid sarcoma

December 18, 2019
The FDA’s Oncologic Drugs Advisory Committee, or ODAC, today voted 11-0 in favor of approval of tazemetostat for the treatment of adults with metastatic or locally…
More Headlines »